In recent few years, increasing evidence has verified that USP21 functions as an oncogene in a variety of human cancers, including gastric cancer, pancreatic cancer, liver cancer, renal cell carcinoma, colorectal cancer, breast cancer, and lung cancer [15, 17–20, 23–25]. The gene discussed is USP21; the disease is hereditary clear cell renal cell carcinoma.